SERPINA1 and ablepharon macrostomia syndrome: The AUC could reach 0.965 after combination of SAP with AAT and LTF, with sensitivity and specificity of 96.2% and 88.9%, suggesting that SAP may be a candidate biomarker for prediction of AMS.